Aldeyra Therapeutics (ALDX) Cash & Current Investments (2013 - 2026)
Aldeyra Therapeutics' Cash & Current Investments was $45.09 million in Q2 2026, down 45.0% from $81.92 million a year earlier and down 30.6% from the prior quarter.
Powered by 
Analysis
Aldeyra Therapeutics (ALDX) Cash & Current Investments (2013 - 2026) Analysis & Trends
At the end of FY2025, Cash & Current Investments at Aldeyra Therapeutics came in at $70.04 million, down 30.8% from FY2024.
- Cash & Current Investments has now declined for three consecutive years, though with a five-year compound annual growth rate of 5.8% (FY2020 to FY2025).
- In earlier years, Cash & Current Investments was $101.15 million in FY2024 (-29.2%), $142.82 million in FY2023 (-18.1%), $174.3 million in FY2022 (+66.3%) and $104.79 million in FY2021 (+98.2%).
- The Q2 2026 figure marks the lowest quarterly Cash & Current Investments since Q1 2020.
- Compared with a year earlier, Cash & Current Investments has declined for three straight quarters, with an average decline of 21.0% over the last eight quarters.
- The best year-over-year quarter for Cash & Current Investments over five years was Q4 2021 (growth of 98.2%); the worst was Q1 2024 (a decline of 49.7%).
- Per Business Quant data, ALDX's Cash & Current Investments in the three quarters before Q2 2026 was $65 million (Q1 2026), $70.04 million (Q4 2025) and $75.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Aldeyra Therapeutics | 39.21 Mn | -216.22 Mn | - | 45.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.09 Mn |
| Mar 31, 2026 | 65.00 Mn |
| Dec 31, 2025 | 70.04 Mn |
| Sep 30, 2025 | 75.30 Mn |
| Jun 30, 2025 | 81.92 Mn |
| Mar 31, 2025 | 90.06 Mn |
| Dec 31, 2024 | 101.15 Mn |
| Sep 30, 2024 | 72.74 Mn |
| Jun 30, 2024 | 80.33 Mn |
| Mar 31, 2024 | 83.04 Mn |
| Dec 31, 2023 | 142.82 Mn |
| Sep 30, 2023 | 143.33 Mn |
| Jun 30, 2023 | 151.68 Mn |
| Mar 31, 2023 | 165.03 Mn |
| Dec 31, 2022 | 174.30 Mn |
| Sep 30, 2022 | 163.83 Mn |
| Jun 30, 2022 | 117.69 Mn |
| Mar 31, 2022 | 151.87 Mn |
| Dec 31, 2021 | 104.79 Mn |
| Sep 30, 2021 | 116.37 Mn |
API Access
Aldeyra Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ALDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ALDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ALDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();